3)List Three Mechanisms of Arrhythmogenesis

3)List Three Mechanisms of Arrhythmogenesis

Pharmacology

Lecture 11 Antiarrhythmic Drugs

1)Define cardiac arrhythmias.Arrhythmias are any abnormalities in heart rate, rhythm or a change in the site of the cardiac pacemaker resulting from alterations in the electrical activity of certain cardiac cells.

2)List the goals of antiarrhythmic therapy with drugs.The goal of antiarrhythmic therapy is to restore normal cardiac function, alleviate symptoms and prevent sudden cardiac death.

3)List three mechanisms of arrhythmogenesis.

Enhanced automaticy – the cardiac impulse originates in cells outside of the SA node that are undergoing spontaneous depolarization at a rate faster than the SA node.

Triggered automaticy – is characterized by after depolarizations, depolarizations that occur before or after full repolarization of the cell. After depolarizations can be early (EAD) or delayed (DAD).

Re-entry – occurs when there is slower conduction down one branch of fibers than on a neighboring branch such that the impulse on the normal branch depolarizes its cells and comes back the wrong direction. This occurs with congenital bypass tracts connecting atrium and ventricle, myocardial ischemia, and electrolyte imbalance. It produces atrial and ventricular fibrillation.

4)For each of the drugs discussed in this section, describe: electrophysiologic actions, antiarrhythmic actions, indications for use and adverse action both cardiac and non-cardiac.

Drug / Electrophysiologic actions / Antiarrhythmic actions / Indications for use / Adverse action
Adenosine / ↑K+ conductance and cAMP-induced Ca2+ influx is inhibited. Inhibits AV nodal conduction and ↑AV nodal refractory period / Activates the adenosine A1 receptor resulting in A-V nodal block / IV use in the emergent treatment of proxysmal supraventricular tachycardia / Cardiac – risk of transient AV block.
Flushing occurs
Ineffective with antagonist theophylline
Amiodarone / Threshold is increased and impulse conduction is slowed / Na+, K+, and Ca2+ ion channel block / Acute ventricular tachycardia and fibrillation, and long-term treatment of atrial fibrillation / Corneal micro-deposits, skin discoloration, thyroid disfunction, liver dysfunction, pulmonary fibrosis
Digoxin / ↓excitability, ↓automaticity, ↓conduction velocity and ↑refractory periods / Block Na+/K+ATPase to ↓HR ↑contractility Vagomimetic / Atrial fibrillation, chronic heart failure / Cardiac – arrhythmias
Fatigue, anorexia, N&V, altered vision and confusion
Lidocaine / Suppresses electrical activity in tissue causing arrhythmias but not in normal tissue / Na+ channel block / Ventricular ectopy and tachycardia associated with hemodynamic instability / Cardiac – least cardiotoxic.
CNS stimulation w/seizures
Propranolol / Decreases automaticity, prolongs the refractory period of the A-V node and slows conduction through the A-V node thus slowing ventricular rate / β-Blockade / Atrial fibrillation to slow ventricular rate, to maintain sinus rhythem post electrical conversion, other supraventricular tachycardias, and after MI / Cardiac – not used in severe or unstable CHF.
Contraindicated – asthma, COPD, severe peripheral vascular disease, diabetes
Verapamil / Affects abnormal tissue more, selectively depresses frequently depolarizing tissue, SA and AV nodal conduction velocity is slowed and the refractory period is prolonged / Ca2+ channel block / Reentrant supravenricular tachycardia, also slows the ventricular rate in atrial fibrillation / Cardiac – worsen CHF, AV block with digoxin or β blockers.
Hypotension